fr_document_number,fr_title,fr_type,publication_date,fr_url,regs_document_id,regs_title,regs_type,agency_id,docket_id
2026-09788,Environmental Impact Statements; Notice of Availability,Notice,2026-05-15,https://www.federalregister.gov/documents/2026/05/15/2026-09788/environmental-impact-statements-notice-of-availability,EPA_FRDOC_0001-32815,"Environmental Impact Statements; Availability, etc.",Notice,EPA,EPA_FRDOC_0001
2026-09767,Oscar Bobo: Final Debarment Order,Notice,2026-05-15,https://www.federalregister.gov/documents/2026/05/15/2026-09767/oscar-bobo-final-debarment-order,FDA-2025-N-0421-0002,Oscar Bobo: Final Debarment Order,Notice,FDA,FDA-2025-N-0421
2026-09805,Agency Information Collection Activities; Submission to the Office of Management and Budget; Federal Fish and Wildlife Permit Applications and Reports-Management Authority,Notice,2026-05-15,https://www.federalregister.gov/documents/2026/05/15/2026-09805/agency-information-collection-activities-submission-to-the-office-of-management-and-budget-federal,FWS-HQ-IA-2026-1915-0001,Agency Information Collection Activities; Submission to the Office of Management and Budget; Federal Fish and Wildlife Permit Applications and Reports-Management Authority,Notice,FWS,FWS-HQ-IA-2026-1915
2026-09751,Agency Information Collection Activities; Submission to the Office of Management and Budget; Horseshoe Crab and Cooperative Fish Tagging Programs,Notice,2026-05-15,https://www.federalregister.gov/documents/2026/05/15/2026-09751/agency-information-collection-activities-submission-to-the-office-of-management-and-budget-horseshoe,FWS-R5-FAC-2026-1684-0001,Agency Information Collection Activities; Submission to the Office of Management and Budget; Horseshoe Crab and Cooperative Fish Tagging Programs,Notice,FWS,FWS-R5-FAC-2026-1684
2026-09807,Foreign Endangered Species; Receipt of Permit Applications,Notice,2026-05-15,https://www.federalregister.gov/documents/2026/05/15/2026-09807/foreign-endangered-species-receipt-of-permit-applications,FWS-HQ-IA-2026-0298-0001,Foreign Endangered Species; Receipt of Permit Applications,Notice,FWS,FWS-HQ-IA-2026-0298
2026-09833,Request for Information on Modified Organisms Subject to the Plant Protection Act,Proposed Rule,2026-05-15,https://www.federalregister.gov/documents/2026/05/15/2026-09833/request-for-information-on-modified-organisms-subject-to-the-plant-protection-act,USDA_FRDOC_0001-3307,Modified Organisms Subject to the Plant Protection Act,Proposed Rule,USDA,USDA_FRDOC_0001
2026-09695,General Conference Committee of the National Poultry Improvement Plan; Solicitation for Membership,Notice,2026-05-14,https://www.federalregister.gov/documents/2026/05/14/2026-09695/general-conference-committee-of-the-national-poultry-improvement-plan-solicitation-for-membership,APHIS-2026-0101-0001,Requests for Nominations: General Conference Committee of the National Poultry Improvement Plan,Notice,APHIS,APHIS-2026-0101
2026-09639,"Notice of Request for Revision To and Extension of Approval of an Information Collection; Restrictions on Importation of Live Poultry, Poultry Meat, and Other Poultry Products From Specified Regions",Notice,2026-05-14,https://www.federalregister.gov/documents/2026/05/14/2026-09639/notice-of-request-for-revision-to-and-extension-of-approval-of-an-information-collection,APHIS-2026-0496-0001,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Restrictions on Importation of Live Poultry, Poultry Meat, and Other Poultry Products from Specified Regions",Notice,APHIS,APHIS-2026-0496
2026-09618,Air Plan Approval; Minnesota; Metropolitan Council Wastewater Treatment Plant Title I PM10 SIP Revisions,Rule,2026-05-14,https://www.federalregister.gov/documents/2026/05/14/2026-09618/air-plan-approval-minnesota-metropolitan-council-wastewater-treatment-plant-title-i-pm10-sip,EPA-R05-OAR-2024-0268-0014,Final approval of the Minnesota MCES PM10 SIP revision,Rule,EPA,EPA-R05-OAR-2024-0268
2026-09613,Air Plan Approval; Illinois; Moderate Attainment Plan Elements for the Chicago and Metro East Areas for the 2015 Ozone Standard,Rule,2026-05-14,https://www.federalregister.gov/documents/2026/05/14/2026-09613/air-plan-approval-illinois-moderate-attainment-plan-elements-for-the-chicago-and-metro-east-areas,EPA-R05-OAR-2024-0617-0005,Final approval of the Illinois 2015 Ozone Moderate Attainment Plan Elements for Chicago and Metro-East St. Louis,Rule,EPA,EPA-R05-OAR-2024-0617
2026-09612,Air Plan Approval; Indiana; Indiana NOX Emissions Monitoring,Rule,2026-05-14,https://www.federalregister.gov/documents/2026/05/14/2026-09612/air-plan-approval-indiana-indiana-nox-emissions-monitoring,EPA-R05-OAR-2021-0761-0006,Final approval of Indiana NOx Emissions Monitoring,Rule,EPA,EPA-R05-OAR-2021-0761
2026-09588,Clean Air Act Tribal Minor New Source Review Permit Issued to Jamul Casino Resort,Notice,2026-05-14,https://www.federalregister.gov/documents/2026/05/14/2026-09588/clean-air-act-tribal-minor-new-source-review-permit-issued-to-jamul-casino-resort,EPA-R09-OAR-2025-0454-0026,"Permits; Applications, Issuances, etc.: Jamul Casino Resort, Clean Air Act Tribal Minor New Source Review",Notice,EPA,EPA-R09-OAR-2025-0454
2026-09604,"Determination of Attainment by the Attainment Date and Clean Data Determination for the 2012 Annual Fine Particulate Standard; Plumas County, California",Proposed Rule,2026-05-14,https://www.federalregister.gov/documents/2026/05/14/2026-09604/determination-of-attainment-by-the-attainment-date-and-clean-data-determination-for-the-2012-annual,EPA-R09-OAR-2026-2608-0001,"Air Quality State Implementation Plans; Approvals and Promulgations: Determination of Attainment by the Attainment Date and Clean Data Determination for the 2012 Annual Fine Particulate Standard; Plumas County, CA",Proposed Rule,EPA,EPA-R09-OAR-2026-2608
2026-09613,Air Plan Approval; Illinois; Moderate Attainment Plan Elements for the Chicago and Metro East Areas for the 2015 Ozone Standard,Rule,2026-05-14,https://www.federalregister.gov/documents/2026/05/14/2026-09613/air-plan-approval-illinois-moderate-attainment-plan-elements-for-the-chicago-and-metro-east-areas,EPA-R05-OAR-2024-0618-0006,Final approval of the Illinois 2015 Ozone Moderate Attainment Plan Elements for Chicago and Metro-East St. Louis,Rule,EPA,EPA-R05-OAR-2024-0618
2026-09615,Approval and Promulgation of Delegation of Authority for Designated Facilities and Pollutants; Washington; Northwest Clean Air Agency,Rule,2026-05-14,https://www.federalregister.gov/documents/2026/05/14/2026-09615/approval-and-promulgation-of-delegation-of-authority-for-designated-facilities-and-pollutants,EPA-R10-OAR-2026-0694-0001,State Plans for Designated Facilities and Pollutants; Approvals and Promulgations: Washington; Northwest Clean Air Agency,Rule,EPA,EPA-R10-OAR-2026-0694
2026-09616,Air Plan Approval; Michigan; Infrastructure SIP Requirements for the 2015 Ozone NAAQS; Michigan State Board Requirements,Rule,2026-05-14,https://www.federalregister.gov/documents/2026/05/14/2026-09616/air-plan-approval-michigan-infrastructure-sip-requirements-for-the-2015-ozone-naaqs-michigan-state,EPA-R05-OAR-2019-0215-0014,Final approval of Michigan 2015 Ozone iSIP Element E State Board Requirements,Rule,EPA,EPA-R05-OAR-2019-0215
2026-09586,Environmental Protection Agency Draft Fiscal Year 2027 Evidence Plan; Extension of Comment Period,Notice,2026-05-14,https://www.federalregister.gov/documents/2026/05/14/2026-09586/environmental-protection-agency-draft-fiscal-year-2027-evidence-plan-extension-of-comment-period,EPA_FRDOC_0001-32804,Draft Fiscal Year 2027 Evidence Plan,Notice,EPA,EPA_FRDOC_0001
2026-09587,"Proposed CERCLA Cost Recovery Settlement for the Desha Road Superfund Site, Tappahannock, Essex County, Virginia",Notice,2026-05-14,https://www.federalregister.gov/documents/2026/05/14/2026-09587/proposed-cercla-cost-recovery-settlement-for-the-desha-road-superfund-site-tappahannock-essex-county,EPA_FRDOC_0001-32807,"Proposed Settlement Agreement, Stipulation, Order, and Judgment, etc.: CERCLA; Cost Recovery for the Desha Road Superfund Site, Tappahannock, Essex County, VA",Notice,EPA,EPA_FRDOC_0001
2026-09614,"Air Plan Approval; Ohio; Clean Data Determination for the Cleveland, Ohio Area for the 2015 Ozone Standard",Rule,2026-05-14,https://www.federalregister.gov/documents/2026/05/14/2026-09614/air-plan-approval-ohio-clean-data-determination-for-the-cleveland-ohio-area-for-the-2015-ozone,EPA-R05-OAR-2026-0562-0024,"Final approval of the Cleveland, Ohio 2015 Ozone Clean Data Determination",Rule,EPA,EPA-R05-OAR-2026-0562
2026-09619,Air Plan Approval; Montana; Revisions to Western Sugar Stipulation,Rule,2026-05-14,https://www.federalregister.gov/documents/2026/05/14/2026-09619/air-plan-approval-montana-revisions-to-western-sugar-stipulation,EPA-R08-OAR-2025-2070-0009,Air Quality State Implementation Plans; Approvals and Promulgations: Montana; Revisions to Western Sugar Stipulation,Rule,EPA,EPA-R08-OAR-2025-2070
2026-09603,Alaska: Tentative Determination on Final Authorization of State Hazardous Waste Management Program,Proposed Rule,2026-05-14,https://www.federalregister.gov/documents/2026/05/14/2026-09603/alaska-tentative-determination-on-final-authorization-of-state-hazardous-waste-management-program,EPA-R10-RCRA-2026-2146-0009,State Hazardous Waste Management Program: Alaska; Tentative Determination on Final Authorization,Proposed Rule,EPA,EPA-R10-RCRA-2026-2146
2026-09585,2026 Annual Joint Meeting of the Ozone Transport Commission and the Mid-Atlantic Northeast Visibility Union,Notice,2026-05-14,https://www.federalregister.gov/documents/2026/05/14/2026-09585/2026-annual-joint-meeting-of-the-ozone-transport-commission-and-the-mid-atlantic-northeast,EPA_FRDOC_0001-32810,"Hearings, Meetings, Proceedings, etc.: Ozone Transport Commission and the Mid-Atlantic Northeast Visibility Union",Notice,EPA,EPA_FRDOC_0001
2026-09645,Submission for OMB Review; Comment Request; Reinstatement,Notice,2026-05-14,https://www.federalregister.gov/documents/2026/05/14/2026-09645/submission-for-omb-review-comment-request-reinstatement,USDA_FRDOC_0001-3306,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,USDA,USDA_FRDOC_0001
2026-09519,Notice of Request for Extension of Approval of an Information Collection; Federally Recognized State Managed Phytosanitary Program,Notice,2026-05-13,https://www.federalregister.gov/documents/2026/05/13/2026-09519/notice-of-request-for-extension-of-approval-of-an-information-collection-federally-recognized-state,APHIS-2026-0431-0001,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Federally Recognized State Managed Phytosanitary Program",Notice,APHIS,APHIS-2026-0431
2026-09490,"Oxirane, 2-phenyl-, polymer With oxirane, mono(hydrogen 2-sulfobutanedioate), octyl ether, sodium salt (1:2) in Pesticide Formulations; Exemption From the Requirement for a Tolerance",Rule,2026-05-13,https://www.federalregister.gov/documents/2026/05/13/2026-09490/oxirane-2-phenyl--polymer-with-oxirane-monohydrogen-2-sulfobutanedioate-octyl-ether-sodium-salt-12,EPA-HQ-OPP-2025-3360-0004,"Pesticide Tolerance; Exemptions, Petitions, Revocations, etc.: Oxirane, 2-phenyl-, polymer with oxirane, mono(hydrogen 2-sulfobutanedioate), octyl ether, sodium salt (1:2) in Pesticide Formulations",Rule,EPA,EPA-HQ-OPP-2025-3360
2026-09524,Begin Actual Construction in the New Source Review (NSR) Preconstruction Permitting Program,Proposed Rule,2026-05-13,https://www.federalregister.gov/documents/2026/05/13/2026-09524/begin-actual-construction-in-the-new-source-review-nsr-preconstruction-permitting-program,EPA-HQ-OAR-2025-0618-0001,Begin Actual Construction in the New Source Review Preconstruction Permitting Program,Proposed Rule,EPA,EPA-HQ-OAR-2025-0618
2026-09508,Azodicarbonamide (ADA); Request for Information,Notice,2026-05-13,https://www.federalregister.gov/documents/2026/05/13/2026-09508/azodicarbonamide-ada-request-for-information,FDA-2026-N-4126-0001,Azodicarbonamide (ADA); Request for Information,Notice,FDA,FDA-2026-N-4126
2026-09543,Agency Information Collection Activities; Proposed Collection; Comment Request; Postmarketing Adverse Experience Reporting,Notice,2026-05-13,https://www.federalregister.gov/documents/2026/05/13/2026-09543/agency-information-collection-activities-proposed-collection-comment-request-postmarketing-adverse,FDA-2026-N-3098-0001,Agency Information Collection Activities; Proposed Collection; Comment Request; Postmarketing Adverse Experience Reporting,Notice,FDA,FDA-2026-N-3098
2026-09507,Butylated Hydroxytoluene (BHT); Request for Information,Notice,2026-05-13,https://www.federalregister.gov/documents/2026/05/13/2026-09507/butylated-hydroxytoluene-bht-request-for-information,FDA-2026-N-2526-0001,Butylated Hydroxytoluene (BHT); Request for Information,Notice,FDA,FDA-2026-N-2526
2026-09544,"Modified Risk Tobacco Product Application: Renewal Applications for VLN® King and VLN® Menthol King, Cigarette Products Submitted by 22nd Century Group Inc.",Notice,2026-05-13,https://www.federalregister.gov/documents/2026/05/13/2026-09544/modified-risk-tobacco-product-application-renewal-applications-for-vln-king-and-vln-menthol-king,FDA-2019-N-0994-0230,"Modified Risk Tobacco Product Application: Renewal Applications for
VLN® King and VLN® Menthol King, Cigarette Products Submitted by 22nd Century Group Inc.",Notice,FDA,FDA-2019-N-0994
2026-09448,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; The Real Cost Campaign Outcomes Evaluation Study: Cohort 3,Notice,2026-05-13,https://www.federalregister.gov/documents/2026/05/13/2026-09448/agency-information-collection-activities-submission-for-office-of-management-and-budget-review,FDA-2025-N-1600-0003,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; The Real Cost Campaign Outcomes Evaluation Study: Cohort 3,Notice,FDA,FDA-2025-N-1600
2026-09533,Biomarker Incubator: Urinary Kidney Safety Biomarkers; Request for Information,Notice,2026-05-13,https://www.federalregister.gov/documents/2026/05/13/2026-09533/biomarker-incubator-urinary-kidney-safety-biomarkers-request-for-information,FDA-2026-N-0005-0001,Biomarker Incubator: Urinary Kidney Safety Biomarkers; Request for Information,Notice,FDA,FDA-2026-N-0005
2026-09370,Science Applications International Corporation; Access to Confidential Business Information,Notice,2026-05-12,https://www.federalregister.gov/documents/2026/05/12/2026-09370/science-applications-international-corporation-access-to-confidential-business-information,EPA-HQ-OPPT-2003-0004-0151,Access to Confidential Business Information: Science Applications International Corp.,Notice,EPA,EPA-HQ-OPPT-2003-0004
2026-09366,Drug Repurposing for Unmet Medical Needs; Request for Information,Notice,2026-05-12,https://www.federalregister.gov/documents/2026/05/12/2026-09366/drug-repurposing-for-unmet-medical-needs-request-for-information,FDA-2026-N-4492-0001,Drug Repurposing for Unmet Medical Needs; Request for Information,Notice,FDA,FDA-2026-N-4492
2026-09438,21st Century Cures Act: Annual Compilation of Notices of Updates From the Susceptibility Test Interpretive Criteria web page,Notice,2026-05-12,https://www.federalregister.gov/documents/2026/05/12/2026-09438/21st-century-cures-act-annual-compilation-of-notices-of-updates-from-the-susceptibility-test,FDA-2017-N-5925-0040,21st Century Cures Act: Annual Compilation of Notices of Updates From the Susceptibility Test Interpretive Criteria web page,Notice,FDA,FDA-2017-N-5925
2026-09368,Enforcement Priorities for Certain New Tobacco Products Marketed Without Premarket Authorization; Guidance for Industry; Availability,Notice,2026-05-12,https://www.federalregister.gov/documents/2026/05/12/2026-09368/enforcement-priorities-for-certain-new-tobacco-products-marketed-without-premarket-authorization,FDA-2026-D-5083-0001,Enforcement Priorities for Certain New Tobacco Products Marketed Without Premarket Authorization; Guidance for Industry; Availability,Notice,FDA,FDA-2026-D-5083
2026-09335,Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect and Identify Microorganism Nucleic Acids and Resistance Markers From Patients With Suspected Orthopedic Infection,Rule,2026-05-12,https://www.federalregister.gov/documents/2026/05/12/2026-09335/medical-devices-immunology-and-microbiology-devices-classification-of-the-device-to-detect-and,FDA-2026-N-4274-0001,Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect and Identify Microorganism Nucleic Acids and Resistance Markers From Patients With Suspected Orthopedic Infection,Rule,FDA,FDA-2026-N-4274
2026-09244,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Testing Communications On Medical Devices and Radiation-Emitting Products,Notice,2026-05-11,https://www.federalregister.gov/documents/2026/05/11/2026-09244/agency-information-collection-activities-submission-for-office-of-management-and-budget-review,FDA-2025-N-2220-0002,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Testing Communications On Medical Devices and Radiation-Emitting Products,Notice,FDA,FDA-2025-N-2220
2026-09284,Animal Generic Drug User Fee Act; Stakeholder Consultation Meetings on the Animal Generic Drug User Fee Act Reauthorization; Request for Notification of Stakeholder Intent To Participate,Notice,2026-05-11,https://www.federalregister.gov/documents/2026/05/11/2026-09284/animal-generic-drug-user-fee-act-stakeholder-consultation-meetings-on-the-animal-generic-drug-user,FDA-2011-N-0655-0042,"Animal Generic Drug User Fee Act; Stakeholder Consultation Meetings on the Animal Generic Drug User Fee Act Reauthorization; Request for
Notification of Stakeholder Intent To Participate",Notice,FDA,FDA-2011-N-0655
2026-09242,Issuance of Priority Review Voucher; Rare Pediatric Disease Product; AVLAYAH (tividenofusp alfa-eknm),Notice,2026-05-11,https://www.federalregister.gov/documents/2026/05/11/2026-09242/issuance-of-priority-review-voucher-rare-pediatric-disease-product-avlayah-tividenofusp-alfa-eknm,FDA-2026-N-4573-0001,Issuance of Priority Review Voucher; Rare Pediatric Disease Product; AVLAYAH (tividenofusp alfa-eknm),Notice,FDA,FDA-2026-N-4573
2026-09269,Pulmonary Tuberculosis: Developing Drugs for Treatment; Guidance for Industry; Availability,Notice,2026-05-11,https://www.federalregister.gov/documents/2026/05/11/2026-09269/pulmonary-tuberculosis-developing-drugs-for-treatment-guidance-for-industry-availability,FDA-2013-D-1319-0015,Pulmonary Tuberculosis: Developing Drugs for Treatment; Guidance for Industry; Availability,Notice,FDA,FDA-2013-D-1319
2026-09268,Postapproval Pregnancy Safety Studies; Guidance for Industry; Availability,Notice,2026-05-11,https://www.federalregister.gov/documents/2026/05/11/2026-09268/postapproval-pregnancy-safety-studies-guidance-for-industry-availability,FDA-2018-D-4693-0022,Postapproval Pregnancy Safety Studies; Guidance for Industry; Availability,Notice,FDA,FDA-2018-D-4693
2026-09283,Animal Drug User Fee Act; Stakeholder Consultation Meetings on the Animal Drug User Fee Act Reauthorization; Request for Notification of Stakeholder Intent To Participate,Notice,2026-05-11,https://www.federalregister.gov/documents/2026/05/11/2026-09283/animal-drug-user-fee-act-stakeholder-consultation-meetings-on-the-animal-drug-user-fee-act,FDA-2011-N-0656-1315,"Animal Drug User Fee Act; Stakeholder Consultation Meetings on the Animal Drug User Fee Act Reauthorization; Request for Notification of Stakeholder
Intent To Participate",Notice,FDA,FDA-2011-N-0656
2026-09267,"Clostridioides Difficile Infection: Developing Drugs for Treatment, Reduction of Recurrence, or Prevention; Guidance for Industry; Availability",Notice,2026-05-11,https://www.federalregister.gov/documents/2026/05/11/2026-09267/clostridioides-difficile-infection-developing-drugs-for-treatment-reduction-of-recurrence-or,FDA-2022-D-1261-0003,"Clostridioides Difficile Infection: Developing Drugs for Treatment, Reduction of Recurrence, or Prevention; Guidance for Industry; Availability",Notice,FDA,FDA-2022-D-1261
2026-09233,Foreign Endangered Species; Receipt of Permit Applications,Notice,2026-05-11,https://www.federalregister.gov/documents/2026/05/11/2026-09233/foreign-endangered-species-receipt-of-permit-applications,FWS-HQ-IA-2026-0760-0001,Foreign Endangered Species; Receipt of Permit Applications,Notice,FWS,FWS-HQ-IA-2026-0760
2026-09234,Foreign Endangered Species; Receipt of Permit Applications,Notice,2026-05-11,https://www.federalregister.gov/documents/2026/05/11/2026-09234/foreign-endangered-species-receipt-of-permit-applications,FWS-HQ-IA-2026-1057-0001,Foreign Endangered Species; Receipt of Permit Applications,Notice,FWS,FWS-HQ-IA-2026-1057
2026-09180,Environmental Impact Statements; Notice of Availability,Notice,2026-05-08,https://www.federalregister.gov/documents/2026/05/08/2026-09180/environmental-impact-statements-notice-of-availability,EPA_FRDOC_0001-32797,"Environmental Impact Statements; Availability, etc.",Notice,EPA,EPA_FRDOC_0001
2026-09146,Air Plan Approval; NC; Removal of the State's Vehicle Inspection and Maintenance Program,Proposed Rule,2026-05-08,https://www.federalregister.gov/documents/2026/05/08/2026-09146/air-plan-approval-nc-removal-of-the-states-vehicle-inspection-and-maintenance-program,EPA-R04-OAR-2025-0305-0009,Air Quality State Implementation Plans; Approvals and Promulgations: North Carolina; Removal of the State's Vehicle Inspection and Maintenance Program,Proposed Rule,EPA,EPA-R04-OAR-2025-0305
2026-09179,Definition of Hazardous Waste Applicable to Corrective Action for Releases From Solid Waste Management Units; Withdrawal,Proposed Rule,2026-05-08,https://www.federalregister.gov/documents/2026/05/08/2026-09179/definition-of-hazardous-waste-applicable-to-corrective-action-for-releases-from-solid-waste,EPA-HQ-OLEM-2023-0085-0082,Definition of Hazardous Waste Applicable to Corrective Action for Releases from Solid Waste Management Units; Withdrawal,Proposed Rule,EPA,EPA-HQ-OLEM-2023-0085
2026-09199,"Determination That Leucovorin Calcium, Oral Solution, Equivalent to 60 Milligrams Base/Vial, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,2026-05-08,https://www.federalregister.gov/documents/2026/05/08/2026-09199/determination-that-leucovorin-calcium-oral-solution-equivalent-to-60-milligrams-basevial-was-not,FDA-2026-P-0749-0004,"Determination That Leucovorin Calcium, Oral Solution, Equivalent to 60 Milligrams Base/Vial, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,FDA,FDA-2026-P-0749
2026-09152,Medical Devices; Obstetrical and Gynecological Devices; Classification of the External Condom for Anal Intercourse or Vaginal Intercourse,Rule,2026-05-08,https://www.federalregister.gov/documents/2026/05/08/2026-09152/medical-devices-obstetrical-and-gynecological-devices-classification-of-the-external-condom-for-anal,FDA-2026-N-4659-0001,Medical Devices; Obstetrical and Gynecological Devices; Classification of the External Condom for Anal Intercourse or Vaginal Intercourse,Rule,FDA,FDA-2026-N-4659
2026-09055,Air Quality Plan; California; San Diego County Air Pollution Control District; Landfill Flares,Proposed Rule,2026-05-07,https://www.federalregister.gov/documents/2026/05/07/2026-09055/air-quality-plan-california-san-diego-county-air-pollution-control-district-landfill-flares,EPA-R09-OAR-2025-1641-0001,Air Quality State Implementation Plans; Approvals and Promulgations: California; San Diego County Air Pollution Control District; Landfill Flares,Proposed Rule,EPA,EPA-R09-OAR-2025-1641
2026-09042,Virginia; Waters of the Northern Neck Peninsula Vessel Sewage No-Discharge Zone; Final Affirmative Determination,Notice,2026-05-07,https://www.federalregister.gov/documents/2026/05/07/2026-09042/virginia-waters-of-the-northern-neck-peninsula-vessel-sewage-no-discharge-zone-final-affirmative,EPA-R03-OW-2025-2004-0006,Final Affirmative Determination: Virginia; Waters of the Northern Neck Peninsula Vessel Sewage No-Discharge Zone,Notice,EPA,EPA-R03-OW-2025-2004
2026-09043,Approval and Promulgation of Delegation of Authority for Designated Facilities and Pollutants; Allegheny County; Delegation of Authority of the Federal Plan for Existing Sewage Sludge Incineration Units,Rule,2026-05-07,https://www.federalregister.gov/documents/2026/05/07/2026-09043/approval-and-promulgation-of-delegation-of-authority-for-designated-facilities-and-pollutants,EPA-R03-OAR-2025-0487-0007,State Plans for Designated Facilities and Pollutants; Approvals and Promulgations: Allegheny County; Delegation of Authority of the Federal Plan for Existing Sewage Sludge Incineration Units,Rule,EPA,EPA-R03-OAR-2025-0487
2026-09053,"Clean Air Act Operating Permit Program; Order on Petitions for Objection to State Operating Permits for Bargath, LLC's Clough, Heath, Hyrup, Jangles and Starkey Gulch Compressor Stations, and Grand River Gathering, LLC's East Mamm Creek Compressor Station",Notice,2026-05-07,https://www.federalregister.gov/documents/2026/05/07/2026-09053/clean-air-act-operating-permit-program-order-on-petitions-for-objection-to-state-operating-permits,EPA_FRDOC_0001-32793,"Clean Air Act Operating Permit Program: Order on Petitions for Objection to State Operating Permits for Bargath, LLC's Clough, Heath, Hyrup, Jangles and Starkey Gulch Compressor Stations, and Grand River Gathering, LLC's East Mamm Creek Compressor Station",Notice,EPA,EPA_FRDOC_0001
2026-09054,Air Plan Approval; Missouri; Attainment Plan for the New Madrid Nonattainment Area for the 2010 1-Hour Sulfur Dioxide National Ambient Air Quality Standard,Proposed Rule,2026-05-07,https://www.federalregister.gov/documents/2026/05/07/2026-09054/air-plan-approval-missouri-attainment-plan-for-the-new-madrid-nonattainment-area-for-the-2010-1-hour,EPA-R07-OAR-2026-2938-0001,Air Quality State Implementation Plans; Approvals and Promulgations: Missouri; Attainment Plan for the New Madrid Nonattainment Area for the 2010 1-hour Sulfur Dioxide National Ambient Air Quality Standard,Proposed Rule,EPA,EPA-R07-OAR-2026-2938
2026-09011,"Determination That MICARDIS (Telmisartan), Tablets, 20 Milligrams and 80 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,2026-05-07,https://www.federalregister.gov/documents/2026/05/07/2026-09011/determination-that-micardis-telmisartan-tablets-20-milligrams-and-80-milligrams-were-not-withdrawn,FDA-2025-P-7054-0006,"Determination That MICARDIS (Telmisartan), Tablets, 20 Milligrams and 80 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,FDA,FDA-2025-P-7054
2026-09023,Patient-Matched Guides for Orthopedic Implants; Guidance for Industry and Food and Drug Administration Staff; Availability,Notice,2026-05-07,https://www.federalregister.gov/documents/2026/05/07/2026-09023/patient-matched-guides-for-orthopedic-implants-guidance-for-industry-and-food-and-drug,FDA-2023-D-2370-0007,Patient-Matched Guides for Orthopedic Implants; Guidance for Industry and Food and Drug Administration Staff; Availability,Notice,FDA,FDA-2023-D-2370
2026-09012,"Teva Pharmaceuticals USA, Inc., et al.; Withdrawal of Approval of 15 Abbreviated New Drug Applications",Notice,2026-05-07,https://www.federalregister.gov/documents/2026/05/07/2026-09012/teva-pharmaceuticals-usa-inc-et-al-withdrawal-of-approval-of-15-abbreviated-new-drug-applications,FDA-2026-N-4291-0001,"Teva Pharmaceuticals USA, Inc., et al.; Withdrawal of Approval of 15 Abbreviated New Drug Applications",Notice,FDA,FDA-2026-N-4291
2026-09108,Advisory Committee; Blood Products Advisory Committee; Renewal,Notice,2026-05-07,https://www.federalregister.gov/documents/2026/05/07/2026-09108/advisory-committee-blood-products-advisory-committee-renewal,FDA-2026-N-0008-0004,Advisory Committee; Blood Products Advisory Committee; Renewal,Notice,FDA,FDA-2026-N-0008
2026-09093,"Receipt of Incidental Take Permit Application and Proposed Habitat Conservation Plan for Sand Skink and Blue-Tailed Mole Skink; Polk County, FL; Categorical Exclusion",Notice,2026-05-07,https://www.federalregister.gov/documents/2026/05/07/2026-09093/receipt-of-incidental-take-permit-application-and-proposed-habitat-conservation-plan-for-sand-skink,FWS-R4-ES-2026-0727-0001,"Receipt of Incidental Take Permit Application and Proposed Habitat Conservation Plan for Sand Skink and Blue-tailed Mole Skink; Polk County, FL; Categorical Exclusion (applicant: FLLWCC, LLC / FLOW CC, LLC)",Notice,FWS,FWS-R4-ES-2026-0727
2026-08808,Pesticide Experimental Use Permit; Receipt of Application; Comment Request (December 2025),Notice,2026-05-06,https://www.federalregister.gov/documents/2026/05/06/2026-08808/pesticide-experimental-use-permit-receipt-of-application-comment-request-december-2025,EPA-HQ-OPP-2025-3951-0001,"Permits; Applications, Issuances, etc.: Pesticide Experimental Use",Notice,EPA,EPA-HQ-OPP-2025-3951
2026-08913,Issuance of Priority Review Voucher; Rare Pediatric Disease Product; OTARMENI (lunsotogene parvec-cwha),Notice,2026-05-06,https://www.federalregister.gov/documents/2026/05/06/2026-08913/issuance-of-priority-review-voucher-rare-pediatric-disease-product-otarmeni-lunsotogene-parvec-cwha,FDA-2026-N-4588-0001,Issuance of Priority Review Voucher; Rare Pediatric Disease Product; OTARMENI (lunsotogene parvec-cwha),Notice,FDA,FDA-2026-N-4588
2026-08811,Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Preserve and Stabilize Relative Abundances of Microbial Nucleic Acids in Clinical Samples,Rule,2026-05-06,https://www.federalregister.gov/documents/2026/05/06/2026-08811/medical-devices-immunology-and-microbiology-devices-classification-of-the-device-to-preserve-and,FDA-2026-N-4644-0001,Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Preserve and Stabilize Relative Abundances of Microbial Nucleic Acids in Clinical Samples,Rule,FDA,FDA-2026-N-4644
2026-08939,"Determination That DEXAMETHASONE (Dexamethasone) Elixir, 0.5 Milligrams/5 Milliliters, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,2026-05-06,https://www.federalregister.gov/documents/2026/05/06/2026-08939/determination-that-dexamethasone-dexamethasone-elixir-05-milligrams5-milliliters-was-not-withdrawn,FDA-2026-P-1306-0004,"Determination That DEXAMETHASONE (Dexamethasone) Elixir, 0.5 Milligrams/5 Milliliters, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,FDA,FDA-2026-P-1306
2026-08812,Medical Devices; Immunology and Microbiology Devices; Classification of the Circulating Tumor Cell Enrichment Device,Rule,2026-05-06,https://www.federalregister.gov/documents/2026/05/06/2026-08812/medical-devices-immunology-and-microbiology-devices-classification-of-the-circulating-tumor-cell,FDA-2026-N-4643-0001,Medical Devices; Immunology and Microbiology Devices; Classification of the Circulating Tumor Cell Enrichment Device,Rule,FDA,FDA-2026-N-4643
2026-08813,Medical Devices; Ophthalmic Devices; Classification of the Corneal Storage Medium With Preservatives Including Antifungals,Rule,2026-05-06,https://www.federalregister.gov/documents/2026/05/06/2026-08813/medical-devices-ophthalmic-devices-classification-of-the-corneal-storage-medium-with-preservatives,FDA-2026-N-4645-0001,Medical Devices; Ophthalmic Devices; Classification of the Corneal Storage Medium With Preservatives Including Antifungals,Rule,FDA,FDA-2026-N-4645
2026-08969,"Endangered and Threatened Wildlife and Plants; Initiation of 5-Year Status Reviews for 78 Species in Hawaii, Idaho, Oregon, and California",Notice,2026-05-06,https://www.federalregister.gov/documents/2026/05/06/2026-08969/endangered-and-threatened-wildlife-and-plants-initiation-of-5-year-status-reviews-for-78-species-in,FWS-R1-ES-2026-0959-0001,"Endangered and Threatened Wildlife and Plants; Initiation of 5-Year Status Reviews for 78 Species in Hawaii, Idaho, Oregon, and California",Notice,FWS,FWS-R1-ES-2026-0959
2026-08682,"1,2-Dichloroethane; Final Risk Evaluation Under the Toxic Substances Control Act (TSCA); Notice of Availability",Notice,2026-05-05,https://www.federalregister.gov/documents/2026/05/05/2026-08682/12-dichloroethane-final-risk-evaluation-under-the-toxic-substances-control-act-tsca-notice-of,EPA-HQ-OPPT-2018-0427-0182,"1,2-Dichloroethane; Final Risk Evaluation Under the Toxic Substances Control Act (TSCA); Notice of Availability",Notice,EPA,EPA-HQ-OPPT-2018-0427
2026-08693,"Proposed Information Collection Request; Clean Water State Revolving Fund and Drinking Water State Revolving Fund Programs; EPA ICR No. 1803.10, OMB Control No. 2040-0185",Notice,2026-05-05,https://www.federalregister.gov/documents/2026/05/05/2026-08693/proposed-information-collection-request-clean-water-state-revolving-fund-and-drinking-water-state,EPA-HQ-OW-2002-0059-0029,"Proposed Information Collection Request; Clean Water State Revolving Fund and Drinking Water State Revolving Fund Programs; EPA ICR No. 1803.10, OMB Control No. 2040-0185",Notice,EPA,EPA-HQ-OW-2002-0059
2026-08750,Extension of Postponement of Effectiveness for Certain Provisions of Trichloroethylene (TCE); Regulation Under the Toxic Substances Control Act (TSCA),Rule,2026-05-05,https://www.federalregister.gov/documents/2026/05/05/2026-08750/extension-of-postponement-of-effectiveness-for-certain-provisions-of-trichloroethylene-tce,EPA-HQ-OPPT-2020-0642-0775,Extension of Postponement of Effectiveness for Certain Provisions of Trichloroethylene (TCE); Regulation Under the Toxic Substances Control Act (TSCA),Rule,EPA,EPA-HQ-OPPT-2020-0642
2026-08734,Sport Fishing and Boating Partnership Council; Call for Nominations,Notice,2026-05-05,https://www.federalregister.gov/documents/2026/05/05/2026-08734/sport-fishing-and-boating-partnership-council-call-for-nominations,FWS-HQ-FAC-2026-1123-0001,Sport Fishing and Boating Partnership Council; Call for Nominations,Notice,FWS,FWS-HQ-FAC-2026-1123
2026-08662,Virginia: Approval of State Coal Combustion Residuals Permit Program,Proposed Rule,2026-05-04,https://www.federalregister.gov/documents/2026/05/04/2026-08662/virginia-approval-of-state-coal-combustion-residuals-permit-program,EPA-HQ-OLEM-2025-3325-0001,Virginia: Approval of State Coal Combustion Residuals Permit Program,Proposed Rule,EPA,EPA-HQ-OLEM-2025-3325
2026-08604,Agency Information Collection Activities; Proposed Collection; Comment Request; National Youth Tobacco Survey,Notice,2026-05-04,https://www.federalregister.gov/documents/2026/05/04/2026-08604/agency-information-collection-activities-proposed-collection-comment-request-national-youth-tobacco,FDA-2026-N-3070-0001,Agency Information Collection Activities; Proposed Collection; Comment Request; National Youth Tobacco Survey,Notice,FDA,FDA-2026-N-3070
2026-08579,"Incidental Take Permit Application for the Desert Tortoise; Draft Habitat Conservation Plan and Draft Environmental Assessment; CalPortland-Oro Grande Quarries and Cement Plant, San Bernardino County, CA",Notice,2026-05-04,https://www.federalregister.gov/documents/2026/05/04/2026-08579/incidental-take-permit-application-for-the-desert-tortoise-draft-habitat-conservation-plan-and-draft,FWS-R8-ES-2025-0054-0001,"Incidental Take Permit Application for the Desert Tortoise; Draft Habitat Conservation Plan and Draft Environmental Assessment; CalPortland—Oro Grande Quarries and Cement Plant, San Bernardino County, CA",Notice,FWS,FWS-R8-ES-2025-0054
2026-08574,Endangered and Threatened Species; Receipt of Recovery Permit Applications,Notice,2026-05-04,https://www.federalregister.gov/documents/2026/05/04/2026-08574/endangered-and-threatened-species-receipt-of-recovery-permit-applications,FWS-R3-ES-2026-0860-0001,"Endangered and Threatened Species; Receipt of Recovery Permit Applications (applicant: Missouri Department of Conservation, Warsaw, MO)",Notice,FWS,FWS-R3-ES-2026-0860
2026-08592,Endangered Species; Issuance of Permits,Notice,2026-05-04,https://www.federalregister.gov/documents/2026/05/04/2026-08592/endangered-species-issuance-of-permits,FWS-HQ-IA-2025-1441-0001,"Endangered Species; Issuance of Permits (applicant: Coastal Exotics, Inc.)",Notice,FWS,FWS-HQ-IA-2025-1441
2026-08665,Endangered and Threatened Wildlife and Plants; 12-Month Not-Warranted Finding for the Temblor Legless Lizard,Proposed Rule,2026-05-04,https://www.federalregister.gov/documents/2026/05/04/2026-08665/endangered-and-threatened-wildlife-and-plants-12-month-not-warranted-finding-for-the-temblor-legless,FWS-R8-ES-2026-0299-0001,Endangered and Threatened Species: 12-Month Not-Warranted Finding for the Temblor Legless Lizard,Proposed Rule,FWS,FWS-R8-ES-2026-0299
2026-08518,National Emission Standards for Hazardous Air Pollutants: Ethylene Oxide Emissions Standards for Sterilization Facilities Residual Risk and Technology Review Reconsideration; Extension of Comment Period,Proposed Rule,2026-05-01,https://www.federalregister.gov/documents/2026/05/01/2026-08518/national-emission-standards-for-hazardous-air-pollutants-ethylene-oxide-emissions-standards-for,EPA-HQ-OAR-2019-0178-1675,National Emission Standards for Hazardous Air Pollutants: Ethylene Oxide Emissions Standards for Sterilization Facilities Residual Risk and Technology Review Reconsideration; Extension of Comment Period,Proposed Rule,EPA,EPA-HQ-OAR-2019-0178
2026-08520,Environmental Impact Statements; Notice of Availability,Notice,2026-05-01,https://www.federalregister.gov/documents/2026/05/01/2026-08520/environmental-impact-statements-notice-of-availability,EPA_FRDOC_0001-32784,"Environmental Impact Statements; Availability, etc.",Notice,EPA,EPA_FRDOC_0001
2026-08497,Medical Devices; General and Plastic Surgery Devices; Classification of the Phototherapy Device for Reducing the Appearance of Acute Post-Surgical Incisions,Rule,2026-05-01,https://www.federalregister.gov/documents/2026/05/01/2026-08497/medical-devices-general-and-plastic-surgery-devices-classification-of-the-phototherapy-device-for,FDA-2026-N-4273-0001,"Medical Devices; General and Plastic Surgery Devices; Classification of the Phototherapy Device for Reducing the
Appearance of Acute Post-Surgical Incisions",Rule,FDA,FDA-2026-N-4273
2026-08552,"List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act",Notice,2026-05-01,https://www.federalregister.gov/documents/2026/05/01/2026-08552/list-of-bulk-drug-substances-for-which-there-is-a-clinical-need-under-section-503b-of-the-federal,FDA-2018-N-3240-0377,"List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act",Notice,FDA,FDA-2018-N-3240
2026-08521,Obesity and Drug Dosing: Clinical Pharmacology Considerations; Request for Comments,Notice,2026-05-01,https://www.federalregister.gov/documents/2026/05/01/2026-08521/obesity-and-drug-dosing-clinical-pharmacology-considerations-request-for-comments,FDA-2026-N-3499-0001,Obesity and Drug Dosing: Clinical Pharmacology Considerations; Request for Comments,Notice,FDA,FDA-2026-N-3499
2026-08524,Impacts of Patient-Focused Drug Development Meetings; Establishment of a Public Docket; Request for Information and Comments,Notice,2026-05-01,https://www.federalregister.gov/documents/2026/05/01/2026-08524/impacts-of-patient-focused-drug-development-meetings-establishment-of-a-public-docket-request-for,FDA-2026-N-3947-0001,Impacts of Patient-Focused Drug Development Meetings; Establishment of a Public Docket; Request for Information and Comments,Notice,FDA,FDA-2026-N-3947
2026-08499,Medical Devices; Exemptions From Premarket Notification: Certain Class II Devices; Request for Comments,Notice,2026-05-01,https://www.federalregister.gov/documents/2026/05/01/2026-08499/medical-devices-exemptions-from-premarket-notification-certain-class-ii-devices-request-for-comments,FDA-2026-N-4268-0001,Medical Devices; Exemptions From Premarket Notification: Certain Class II Devices; Request for Comments,Notice,FDA,FDA-2026-N-4268
2026-08531,Rescission of Final Determination: Adoption of Energy Efficiency Standards for New Construction of HUD- and USDA Financed Housing,Notice,2026-05-01,https://www.federalregister.gov/documents/2026/05/01/2026-08531/rescission-of-final-determination-adoption-of-energy-efficiency-standards-for-new-construction-of,USDA_FRDOC_0001-3302,Rescission of Final Determination: Adoption of Energy Efficiency Standards for New Construction of Department of Housing and Urban Development and Department of Agriculture Financed Housing,Notice,USDA,USDA_FRDOC_0001
2026-08418,Notice of Request for Revision to and Extension of Approval of an Information Collection; Pale Cyst Nematode,Notice,2026-04-30,https://www.federalregister.gov/documents/2026/04/30/2026-08418/notice-of-request-for-revision-to-and-extension-of-approval-of-an-information-collection-pale-cyst,APHIS-2026-0331-0001,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Pale Cyst Nematode",Notice,APHIS,APHIS-2026-0331
2026-08379,Environmental Protection Agency Draft Fiscal Year 2027 Evidence Plan,Notice,2026-04-30,https://www.federalregister.gov/documents/2026/04/30/2026-08379/environmental-protection-agency-draft-fiscal-year-2027-evidence-plan,EPA_FRDOC_0001-32781,Draft Fiscal Year 2027 Evidence Plan,Notice,EPA,EPA_FRDOC_0001
2026-08373,"Air Plan Approval; Delaware; Excess Emissions Provisions Pertaining to Periods of Startup, Shutdown and Malfunction Events",Proposed Rule,2026-04-30,https://www.federalregister.gov/documents/2026/04/30/2026-08373/air-plan-approval-delaware-excess-emissions-provisions-pertaining-to-periods-of-startup-shutdown-and,EPA-R03-OAR-2025-0215-0001,"Air Quality State Implementation Plans; Approvals and Promulgations: Delaware; Excess Emissions Provisions Pertaining to Periods of Startup, Shutdown and Malfunction Events",Proposed Rule,EPA,EPA-R03-OAR-2025-0215
2026-08372,Utah; Northern Wasatch Front; 2015 8-Hour Ozone National Ambient Air Quality Standards; Reconsideration and Repeal of Finding of Failure To Attain and Reclassification to a Serious Nonattainment Area; Determination of Attainment by the Moderate Attainment Date But for International Emissions,Proposed Rule,2026-04-30,https://www.federalregister.gov/documents/2026/04/30/2026-08372/utah-northern-wasatch-front-2015-8-hour-ozone-national-ambient-air-quality-standards-reconsideration,EPA-R08-OAR-2024-0552-0004,Air Quality State Implementation Plans; Approvals and Promulgations: Utah; Northern Wasatch Front; 2015 8-Hour Ozone National Ambient Air Quality Standards; Reconsideration and Repeal of Finding of Failure to Attain and Reclassification to a Serious Nonattainment Area; etc.,Proposed Rule,EPA,EPA-R08-OAR-2024-0552
2026-08370,"Comprehensive Environmental Response, Compensation, and Liability Act; Proposed Administrative Settlement Agreement for Recovery of Response Costs; Goodrich Asbestos Superfund Site in Ottawa County, Miami, Oklahoma",Notice,2026-04-30,https://www.federalregister.gov/documents/2026/04/30/2026-08370/comprehensive-environmental-response-compensation-and-liability-act-proposed-administrative,EPA_FRDOC_0001-32782,"Proposed Settlement Agreement, Stipulation, Order, and Judgment, etc.: CERCLA; Goodrich Asbestos Superfund Site in Ottawa County, Miami, OK",Notice,EPA,EPA_FRDOC_0001
2026-08425,Medical Devices; Neurological Devices; Classification of the Brain Temperature Measurement System,Rule,2026-04-30,https://www.federalregister.gov/documents/2026/04/30/2026-08425/medical-devices-neurological-devices-classification-of-the-brain-temperature-measurement-system,FDA-2026-N-4269-0001,Medical Devices; Neurological Devices; Classification of the Brain Temperature Measurement System,Rule,FDA,FDA-2026-N-4269
2026-08390,"Determination FENOGLIDE (Fenofibrate) Tablets, 40 Milligrams and 120 Milligrams, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,2026-04-30,https://www.federalregister.gov/documents/2026/04/30/2026-08390/determination-fenoglide-fenofibrate-tablets-40-milligrams-and-120-milligrams-was-not-withdrawn-from,FDA-2026-P-0655-0003,"Determination FENOGLIDE (Fenofibrate) Tablets, 40 Milligrams and 120 Milligrams, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,FDA,FDA-2026-P-0655
2026-08426,Medical Devices; Cardiovascular Devices; Classification of the Laser-Powered Inferior Vena Cava Filter Retrieval Catheter,Rule,2026-04-30,https://www.federalregister.gov/documents/2026/04/30/2026-08426/medical-devices-cardiovascular-devices-classification-of-the-laser-powered-inferior-vena-cava-filter,FDA-2026-N-3946-0001,Medical Devices; Cardiovascular Devices; Classification of the Laser-Powered Inferior Vena Cava Filter Retrieval Catheter,Rule,FDA,FDA-2026-N-3946
2026-08417,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Hazard Analysis and Critical Control Point Procedures for the Safe and Sanitary Processing and Importing of Juice,Notice,2026-04-30,https://www.federalregister.gov/documents/2026/04/30/2026-08417/agency-information-collection-activities-submission-for-office-of-management-and-budget-review,FDA-2026-N-0499-0002,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Hazard Analysis and Critical Control Point Procedures for the Safe and Sanitary Processing and Importing of Juice,Notice,FDA,FDA-2026-N-0499
2026-08378,Advisory Committee; Pharmacy Compounding Advisory Committee; Renewal,Notice,2026-04-30,https://www.federalregister.gov/documents/2026/04/30/2026-08378/advisory-committee-pharmacy-compounding-advisory-committee-renewal,FDA-2026-N-0008-0003,Advisory Committee; Pharmacy Compounding Advisory Committee; Renewal,Notice,FDA,FDA-2026-N-0008
2026-08435,"Determination That OZEMPIC (Semaglutide) Solution, 2 Milligrams Per 1.5 Milliliters Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,2026-04-30,https://www.federalregister.gov/documents/2026/04/30/2026-08435/determination-that-ozempic-semaglutide-solution-2-milligrams-per-15-milliliters-was-not-withdrawn,FDA-2025-P-3849-0004,"Determination That OZEMPIC (Semaglutide) Solution, 2 Milligrams Per 1.5 Milliliters Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,FDA,FDA-2025-P-3849
2026-08371,Agency Information Collection Activities; Proposed Collection; Comment Request; Good Laboratory Practice Requirements for Nonclinical Laboratory Studies,Notice,2026-04-30,https://www.federalregister.gov/documents/2026/04/30/2026-08371/agency-information-collection-activities-proposed-collection-comment-request-good-laboratory,FDA-2026-N-3532-0001,Agency Information Collection Activities; Proposed Collection; Comment Request; Good Laboratory Practice Requirements for Nonclinical Laboratory Studies,Notice,FDA,FDA-2026-N-3532
2026-08424,Medical Devices; Radiology Devices; Classification of the Radiation Therapy Marking Device,Rule,2026-04-30,https://www.federalregister.gov/documents/2026/04/30/2026-08424/medical-devices-radiology-devices-classification-of-the-radiation-therapy-marking-device,FDA-2026-N-4270-0001,Medical Devices; Radiology Devices; Classification of the Radiation Therapy Marking Device,Rule,FDA,FDA-2026-N-4270
2026-08455,"ChemoCentryx, Inc.; Proposal To Withdraw Approval of New Drug Application for TAVNEOS (Avacopan) Capsule, 10 Milligrams; Opportunity for a Hearing",Notice,2026-04-30,https://www.federalregister.gov/documents/2026/04/30/2026-08455/chemocentryx-inc-proposal-to-withdraw-approval-of-new-drug-application-for-tavneos-avacopan-capsule,FDA-2026-N-1321-0001,"ChemoCentryx, Inc.; Proposal To Withdraw Approval of New Drug Application for TAVNEOS (Avacopan) Capsule, 10 Milligrams; Opportunity for a Hearing",Notice,FDA,FDA-2026-N-1321